ConductScience.org, home

Paper5457933

Antigenicity of cells derived from mouse prostate cells after malignant transformation in vitro by carcinogenic hydrocarbons.

Mondal S and 3 others. Cancer Res, 1970. Cited by 39 papers, by iCite.

Cite this record

ConductScience Library. Antigenicity of cells derived from mouse prostate cells after malignant transformation in vitro by carcinogenic hydrocarbons. Papers, record 5457933. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/5457933

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antigenicity of cells derived from mouse prostate cells after malignant transformation in vitro by carcinogenic hydrocarbons.
PubMed
Journal
Cancer Res
PubMed
Year
1970
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
39
iCite
Relative citation ratio, by iCite
1.41
iCite
Revised in PubMed
2003-11-14
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mondal SS
2Iype PTP T
3Griesbach LML M
4Heidelberger CC

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AntigensMajor topic
Cell Transformation, NeoplasticMajor topic
FibrosarcomaMajor topic
MethylcholanthreneMajor topic
ProstateMajor topic
Sarcoma, ExperimentalMajor topic
Transplantation ImmunologyMajor topic
Animals
Cell Line
Clone Cells
Cross Reactions
Male
Mice

Source PubMed

Download CSV of topics

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 39 citations.

PMIDTitleJournalYearIn PapersSource
6984353The immune response to a chemically induced fibrosarcoma: a comparison of cytolytic T lymphocyte stimulation by transformed and non-transformed fibroblasts.Cancer Immunol Immunother1982https://conductscience.org/library/papers/6984353PubMed
6762248Influence of immune status of host on immunogenicity of tumors induced with two doses of methylcholanthrene.Cancer Immunol Immunother1982https://conductscience.org/library/papers/6762248PubMed
4571664Cell surface antigenic changes induced in normal adult rat liver cells by carcinogen treatment in vitro.Br J Cancer1973https://conductscience.org/library/papers/4571664PubMed
4108174In vitro transformation of rodent cells by K-region derivatives of polycyclic hydrocarbons.Proc Natl Acad Sci U S A1971https://conductscience.org/library/papers/4108174PubMed
200144Considerations on the preneoplastic lesions of the mammary gland.Am J Pathol1977https://conductscience.org/library/papers/200144PubMed
81676Surface antigens of rat liver epithelial cells grown in medium containing foetal bovine serum.Br J Cancer1978https://conductscience.org/library/papers/81676PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/5457933

GET https://conductscience.org/api/papers/v1/5457933/authors